GLIMIRIDE 4mg glimepiride tablet 4mg blister pack

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

glimepiride, Quantity: 4 mg

可用日期:

Micro Labs Pty Ltd

INN（国际名称）:

Glimepiride

药物剂型:

Tablet, uncoated

组成:

Excipient Ingredients: lactose monohydrate; magnesium stearate; sodium starch glycollate type A; povidone; sodium lauryl sulfate; microcrystalline cellulose; indigo carmine aluminium lake

给药途径:

Oral

每包单位数:

blister pack of 30's [15's X 2] in Monocarton

处方类型:

(S4) Prescription Only Medicine

疗效迹象:

Indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

產品總結:

Visual Identification: Light blue coloured capsule shaped uncoated tablet with embossing GM & 4 with score line on one side and score line on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

授权状态:

Licence status A

授权日期:

2016-08-03

产品特点

1
AUSTRALIAN
PRODUCT INFORMATION- GLIMIRIDE TABLETS (GLIMEPIRIDE)
1
NAME OF THE MEDICINE
Glimepiride
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
GLIMIRIDE tablets contain 1 mg, 2 mg, 3 mg or 4 mg of glimepiride.
Excipient with known effect:
Contains sugars as lactose monohydrate
For a full list of excipients, see section 6.1 LIST OF EXCIPIENTS.
3
PHARMACEUTICAL FORM
GLIMIRIDE tablets
•
1.0 mg: Pink coloured capsule shaped tablet with embossing “GM” &
“1” with score line
on one side and score line on the other side.
•
2.0 mg: Pale green coloured capsule shaped tablet with embossing
“GM” & “2” with
score line on one side and score line on the other side.
•
3.0 mg: Pale yellow coloured capsule shaped tablet with embossing
“GM” & “3” with
score line on one side and score line on the other side.
•
4.0 mg: Light blue coloured capsule shaped uncoated tablet with
embossing “GM” & “4”
with score line on one side and score line on the other side.
4
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
GLIMIRIDE is indicated as an adjunct to diet, exercise and weight
loss, to lower the
blood glucose in patients with non-insulin-dependent (type 2) diabetes
mellitus.
4.2 DOSE AND METHOD OF ADMINISTRATION
In the management of type 2 diabetes mellitus, administration of an
oral antidiabetic
agent is not a substitute for appropriate dietary control.
In initiating treatment for type 2 diabetes mellitus, diet should be
emphasised as the
primary form of treatment. Caloric restriction and weight loss are
essential in the
2
obese
diabetic
patient.
Proper
dietary
management
alone
may
be
effective
in
controlling the blood glucose and symptoms of hyperglycaemia. The
importance of
regular physical activity should also be stressed, and cardiovascular
risk factors
should be identified and corrective measures taken where possible.
If this treatment program fails to reduce symptoms and/or blood
glucose, the use of
an oral sulfonylurea should be considered. Use of GLIMIRIDE must be
viewed by
both the physicia